Two Dacheng deals selected as part of China Business Law Journal's Deals of the Year in 2017

China Business Law Journal recently published winners of "Deals of the Year 2017". Two of the deals, advised by Dacheng, received this honor.

1) Financing of Minsheng's Airbus aircraft purchase (led by senior partner Wu Jingjing):

CA-CIB and Korea Development Bank provided financing for 4 Airbus aircrafts that Bluesky 26, the Irish subsidiary of the Chinese company Minsheng Financial Leasing, purchased. Bluesky 26, the borrower, together with its Irish parent company, CA-CIB and Korea Development Bank, signed a range of agreements, including Participation Agreement，Loan Agreement and Proceeds Deed, thus providing various guarantee and credit enhancement methods, such as aircraft mortgage, cash collateral, security assignment, share charge, account pledge, warranty assignment, insurance assignment, etc. In order to effect re-insurance, they also signed new documents with Airbus (the aircraft manufacturer), IAE (the engine manufacturer), and InterGlobe Aviation Limited (the leaseholder). Parties to the transaction signed a large number of core agreements and supporting documents to safeguard the rights and interests of the banks, the borrower, the aircraft manufacturer and the airline.

2) Sisram spin-off, HK listing by Fosun Pharmaceutical (led by senior partners Jason Cheng and Daniel Wei, and associate Siak Zhang):

Sisram Medical was a majority-owned subsidiary of Fosun Pharmaceutical, and its wholly owned subsidiary, Alma Lasers, mainly engages in the research, development, production and sale of devices for cosmetic surgery. Both Sisram Medical and Alma Lasers are registered in Israel, and accordingly this project was essentially the spin-off of a majority-owned subsidiary by an H-share/A-share dual listed company registered in Mainland China, and completion of the listing in Hong Kong. Dacheng was able to demonstrate the soundness of Israel's company law and its comparability with Hong Kong company law through intense liaison with HKEx, and partnering with local Israeli law firms, Israeli legal opinions, etc., ultimately opening a path for an H-share listing by an enterprise registered in Israel.

The winning deals have been chosen by an independent editorial team based on various factors. China Business Law Journal attaches most importance to the overall significance, complexity and innovative nature of the deals and cases, while also taking into account the deal size and broader interests.